BASEL — Novartis Friday confirmed that certain important conditions precedent for the 100% spin-off of the Alcon eye care business have been met, including receipt of certain necessary authorizations and rulings. Completion of the transaction, by way of a distribution of a dividend in kind to Novartis shareholders and ADR (American Depositary Receipt) holders, is expected to be on April 9, 2019. In the distribution, each Novartis shareholder will receive 1 Alcon share for every 5 Novartis shares/ADRs they hold on April 8, 2019, close of business.
Approval has been given, subject to customary conditions, by the SIX Exchange Regulation for the listing of the shares of Alcon Inc. on the SIX Swiss Exchange (SIX) pursuant to the International Reporting Standard. Authorization has also been received for the listing of shares in Alcon Inc. on the New York Stock Exchange (NYSE).
Alcon will seek effectiveness of the Alcon Inc. Form 20-F registration statement from the US Securities and Exchange Commission (SEC). The Alcon Inc. 20-F registration statement is available at www.sec.gov and can also be accessed at the following link after its publication with the SEC: https://www.novartis.com/sites/www.novartis.com/files/alcon-20f-filing-2019.pdf.
Shares in Alcon Inc. are expected to be listed and traded from April 9, 2019 on the SIX and the NYSE under the ticker symbol “ALC”. Alcon will also be included in both the Swiss Market Index (SMI®) and Swiss Performance Index (SPI®) from the first day of trading, as recently announced by the SIX.
Alcon has secured debt financing of USD 3.5 billion through a group of banks. The Alcon credit rating will be investment grade following the spin-off. Moody’s Investor Service and S&P Global Ratings have rated Alcon at Baa2 and BBB, respectively, with a stable outlook.
Bank of America Merrill Lynch and UBS AG are advising Novartis on the transaction.
Novartis plans for Alcon spin-off on April 9, 2019
Novartis Friday confirmed that certain important conditions precedent for the 100% spin-off of the Alcon eye care business have been met, including receipt of certain necessary authorizations and rulings.
Latest
Wahl helps men elevate fall grooming routines with precision beard care tools
As beards make their seasonal return, Wahl offers versatile grooming solutions designed to keep every look sharp, sculpted and intentional.
Apple rolls out new health and fitness features
Apple is adding new health-sensing, readiness, longevity, and women’s health features across Apple Watch and its redesigned Health app.
Hathstauwk announces London Drugs and Fresh St. Market as anchors at Alba in Hastings-Sunrise
Two of British Columbia's most beloved brands bring more than 26,000 square feet of everyday essentials and quality goods and services to the ground floor of the new 157-home rental community at 377 Penticton Street.
Amazon Pharmacy launches full Spanish-language experience
Customers can now manage prescriptions, check costs and connect with pharmacists entirely in Spanish.